Status: Not yet recruiting
ID-ENTITY Trial- Evaluating Serial T-ID Monitoring
To evaluate the association between time-updated CMV and BK viral loads measured monthly by T-ID and the risk of CMV disease and/or biopsy-proven BK virus-associated nephropathy (BKVAN) during the first 12 months following kidney transplantation, accounting for the net immune environment (TTV viral load) and allograft injury (donor-derived cell-free DNA, dd-cfDNA).
Participants needed: 1,000
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Transplant Genomics, Inc.Updated: Feb 24, 2026
Eligibility criteria
Written informed consent and HIPAA authorization obtained prior to any study-rel... [+6]
Recipient of a combined organ transplant involving a non-renal solid organ (e.g.... [+9]